SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?


To: verdad who wrote (2617)4/15/2003 7:53:41 AM
From: CrayUSA  Read Replies (1) | Respond to of 3576
 
07:48 ET GERN Geron Corp receives patent covering use of Telomerase inhibitors (4.40)
Telomerase inhibitors of this type, including GRN163, are currently undergoing pre-clinical testing at Geron for use in treating a range of human cancers.

Cray



To: verdad who wrote (2617)4/22/2003 8:23:28 AM
From: ayn rand  Read Replies (1) | Respond to of 3576
 
GERN going to 2 bucks.

I hope u enjoy mud in the face.